Projected Income Statement: Procter & Gamble

Forecast Balance Sheet: Procter & Gamble

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 24,279 26,361 22,978 24,952 24,196 24,422 23,372 21,694
Change - 8.58% -12.83% 8.59% -3.03% 0.93% -4.3% -7.18%
Announcement Date 7/29/22 A 7/28/23 A 7/30/24 A 7/29/25 A 7/29/26 A - - -
1USD in Million
Estimates

Cash Flow Forecast: Procter & Gamble

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 3,156 3,062 3,322 3,773 4,409 4,355 4,229 4,320
Change - -2.98% 8.49% 13.58% 16.86% -1.23% -2.88% 2.15%
Free Cash Flow (FCF) 1 13,567 13,786 16,524 14,606 15,147 15,490 16,395 17,398
Change - 1.61% 19.86% -11.61% 3.7% 2.27% 5.84% 6.11%
Announcement Date 7/29/22 A 7/28/23 A 7/30/24 A 7/29/25 A 7/29/26 A - - -
1USD in Million
Estimates

Forecast Financial Ratios: Procter & Gamble

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 25.71% 25.42% 27.23% 27.65% 27.18% 27.41% 27.95% 28.3%
EBIT Margin (%) 22.21% 22.11% 23.78% 24.27% 23.55% 23.63% 24.08% 24.4%
EBT Margin (%) 22.44% 22.38% 22.32% 23.93% 23.41% 23.71% 24.19% 24.36%
Net margin (%) 18.38% 17.87% 17.7% 18.95% 18.44% 18.64% 19.19% 19.32%
FCF margin (%) 16.92% 16.81% 19.66% 17.33% 17.4% 17.45% 17.92% 18.4%
FCF / Net Income (%) 92.03% 94.08% 111.06% 91.44% 94.4% 93.66% 93.38% 95.25%

Profitability

        
ROA 12.47% 12.31% 13.39% 12.9% 12.75% 13.31% 13.39% 13.66%
ROE 31.53% 31.2% 30.48% 31.06% 30.11% 30.91% 31.93% 32.63%

Financial Health

        
Leverage (Debt/EBITDA) 1.18x 1.26x 1x 1.07x 1.02x 1x 0.91x 0.81x
Debt / Free cash flow 1.79x 1.91x 1.39x 1.71x 1.6x 1.58x 1.43x 1.25x

Capital Intensity

        
CAPEX / Current Assets (%) 3.94% 3.73% 3.95% 4.48% 5.07% 4.91% 4.62% 4.57%
CAPEX / EBITDA (%) 15.31% 14.69% 14.52% 16.19% 18.64% 17.9% 16.54% 16.14%
CAPEX / FCF (%) 23.26% 22.21% 20.1% 25.83% 29.11% 28.11% 25.8% 24.83%

Items per share

        
Cash flow per share 1 6.586 6.783 8.029 7.259 8.073 8.162 9.084 9.526
Change - 2.99% 18.37% -9.58% 11.21% 1.1% 11.3% 4.87%
Dividend per Share 1 3.523 3.681 3.829 4.076 4.259 4.403 4.6 4.815
Change - 4.47% 4.02% 6.47% 4.48% 3.39% 4.46% 4.68%
Book Value Per Share 1 19.57 19.8 20.45 21.3 22.42 23.64 24.6 25.8
Change - 1.18% 3.28% 4.15% 5.24% 5.45% 4.08% 4.84%
EPS 1 5.81 5.9 6.02 6.51 6.62 6.875 7.381 7.728
Change - 1.55% 2.03% 8.14% 1.69% 3.85% 7.36% 4.7%
Nbr of stocks (in thousands) 2,399,297 2,356,969 2,360,135 2,344,542 2,328,599 2,324,433 2,324,433 2,324,433
Announcement Date 7/29/22 A 7/28/23 A 7/30/24 A 7/29/25 A 7/29/26 A - - -
1USD
Estimates
2027 *2028 *
P/E 21x 19.6x
PBR 6.12x 5.88x
EV / Sales 4.06x 3.93x
Yield 3.04% 3.18%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
144.68USD
Average target price
160.57USD
Spread / Average Target
+10.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PG Stock
  4. PGP Stock
  5. Financials Procter & Gamble